Member Directory
ntl-top-100-logo-345px
Member Directory

Pfizer to Pay $190M in Class Action Settlement over Generic Neurontin

A $190 million settlement has been reached in New York in a consumer fraud class action lawsuit pending against Pfizer which alleges the pharma giant engaged in tactics to delay market entry of generic versions of its epilepsy drug Neurontin.

The lawsuit was filed by purchasers of Neurontin in 2002, claiming Pfizer undertook campaign of sham patent infringement lawsuits and promotion of the drug for unapproved uses in order to maintain market exclusivity. The case is In re Neurontin Antitrust Litigation, No. 02-1390, U.S. District Court, District of New Jersey.

In 2004, Pfizer pleaded guilty to criminal charges of illegal marketing of Neurontin and paid $430 million to federal and state governments.

Find an Attorney

The National Trial Lawyers stands as an esteemed, exclusive association comprising top-tier trial attorneys nationwide. Whether you require a Civil Plaintiff Lawyer or a Criminal Defense Lawyer in your state, our network ensures access to premier legal expertise tailored to your needs.
Find Attorney

Read More Legal News

© Copyright 2022, All Rights Reserved | National Trial Lawyers
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram